Trial Profile
Real Life: Treatment Response in Patients With Symptoms Due to Gastroesophageal Reflux Disease Either With or Without Esophagitis Treated With Pantoprazole Sodium 40 mg o.d. Over 8 Weeks
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Sep 2021
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Sponsors ALTANA Pharma
- 04 May 2012 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.
- 12 Dec 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2007 Status changed from recruiting.